Max Dale Cooper

Title: Max Dale Cooper: Innovator in Monoclonal Variable Lymphocyte Receptors

Introduction

Max Dale Cooper is a prominent inventor based in Atlanta, GA, known for his significant contributions to the field of immunology. With a total of 11 patents to his name, Cooper has made remarkable advancements in the development of soluble monoclonal variable lymphocyte receptors (VLRs) that have potential applications in treating various diseases.

Latest Patents

Cooper's latest patents include innovative methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity. These patents disclose a variety of antigen-specific polypeptides, including soluble, monoclonal, and multivalent forms. The methods outlined in these patents detail the use of polypeptides, antibodies that bind to the antigen-specific polypeptides, and nucleic acids, vectors, and expression systems that encode these polypeptides. Notably, the patents highlight antigen-specific polypeptides that selectively bind pathogens, such as anthrax, and carbohydrates, including blood group determinants. Another significant patent involves a recombinant vector and expression system comprising a nucleic acid encoding a variable lymphocyte receptor (VLR). This disclosure focuses on modifications of VLRs, such as humanized sequences and polypeptides that specifically bind target molecules, with applications in treating or preventing diseases.

Career Highlights

Throughout his career, Max Dale Cooper has worked with esteemed institutions, including the UAB Research Foundation and Emory University. His work has significantly impacted the field of immunology, particularly in the development of therapies that utilize VLRs.

Collaborations

Cooper has collaborated with notable colleagues, including Brantley R. Herrin and Matthew N. Alder, contributing to the advancement of research in his field.

Conclusion

Max Dale Cooper's innovative work in the development of monoclonal variable lymphocyte receptors has paved the way for new therapeutic approaches in immunology. His contributions continue to influence the scientific community and hold promise for future medical advancements.